(AP)—Pharma giant GSK said Thursday it is submitting its malaria vaccine for regulatory approval to the European Medicines Agency.
28 minutes ago
not rated yet | 0
The Leishmania parasite, which causes the human disease leishmaniasis, acts as a probiotic in the insect that transmits it to humans, protecting them from bacterial disease. Findings published in the open a ...
Jul 22, 2014
5 / 5 (1) | 0